ARTICLE | Distillery Therapeutics
Cancer
October 17, 2017 4:44 PM UTC
Cell culture and mouse studies suggest chimeric antigen receptor (CAR) T cells engineered to express an MYD88/CD40-based construct could help treat osteosarcoma and other solid tumors. The CAR T cells...
BCIQ Company Profiles